Related references
Note: Only part of the references are listed.Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
Ravi B. Patel et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
Stefanie Hammer et al.
CLINICAL CANCER RESEARCH (2020)
Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy
Urs B. Hagemann et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
Cytokines that target immune killer cells against tumors
Jian Qiao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Combination Strategies to Improve Targeted Radionuclide Therapy
Tiffany G. Chan et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
Katrine Wickstroem et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers
Urs B. Hagemann et al.
CLINICAL CANCER RESEARCH (2019)
Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality
Eric C. Ko et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)
Cellular and Genetic Determinants of the Sensitivity of Cancer to α-Particle Irradiation
Brian D. Yard et al.
CANCER RESEARCH (2019)
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade
Mohammad Rashidian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Radium-223 mechanism of action: implications for use in treatment combinations
Michael J. Morris et al.
NATURE REVIEWS UROLOGY (2019)
Ovarian Cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis
Nina Mari Gual Pimenta de Queiroz et al.
MOLECULAR CANCER RESEARCH (2019)
How to use immune checkpoint inhibitor in ovarian cancer?
Junsik Park et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma
Jaeyeon Choi et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade
Keaton I. Jones et al.
EMBO MOLECULAR MEDICINE (2018)
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Silvia C. Formenti et al.
NATURE MEDICINE (2018)
Targeted Alpha Therapy, an Emerging Class of Cancer Agents A Review
Christopher Parker et al.
JAMA ONCOLOGY (2018)
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2017)
Cytokine profile of breast cell lines after different radiation doses
Valentina Bravata et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes
Yayi He et al.
MEDICAL SCIENCE MONITOR (2017)
Targeted therapy of ovarian cancer including immune check point inhibitor
Jin Young Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2017)
PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
Jan Willem Kleinovink et al.
ONCOIMMUNOLOGY (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
Aurore Morello et al.
CANCER DISCOVERY (2016)
Dendritic Cells and Cancer Immunity
Alycia Gardner et al.
TRENDS IN IMMUNOLOGY (2016)
Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas' sensitivity to lysis by antigenspecific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation
Anthony S. Malamas et al.
ONCOTARGET (2016)
Evaluation of 68Ga- and 177Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma
Wissam Beaino et al.
MOLECULAR PHARMACEUTICS (2015)
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade
Philipp Mueller et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
PD-1 Restrains Radiotherapy-Induced Abscopal Effect
Sean S. Park et al.
CANCER IMMUNOLOGY RESEARCH (2015)
IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4+ T cells and promoting CTL persistence in a murine model of plasmacytoma
Lixin Wang et al.
ONCOIMMUNOLOGY (2015)
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Sofia R. Gameiro et al.
ONCOTARGET (2014)
Antitumor Immunity Induced after α Irradiation
Jean-Baptiste Gorin et al.
NEOPLASIA (2014)
Combinations of immunotherapy and radiation in cancer therapy
Ralph E. Vatner et al.
FRONTIERS IN ONCOLOGY (2014)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Up-regulation of the Pro-inflammatory Chemokine CXCL16 is a Common Response of Tumor Cells to Ionizing Radiation
Satoko Matsumura et al.
RADIATION RESEARCH (2010)
Mesothelin targeted cancer immunotherapy
Raffit Hassan et al.
EUROPEAN JOURNAL OF CANCER (2008)
Share Paper
